Skip to content

Lab assay

Showing 37–43 of 43 results

Etanercept Drug Level ELISA (RUO) (IDKmonitor®)

Lab assay
The IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis. For research use only.

Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (free- and bound- anti-drug antibodies) in serum and plasma.

Adalimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat inflammatory bowel disease (IBD) and other chronic inflammatory conditions. The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free adalimumab from plasma or serum samples.

Infliximab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response. IDKmonitor Infliximab Free Anti-drug Antibody ELISA is an assay that detects human antibodies against infliximab in EDTA plasma and serum samples.

Golimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Free Anti-drug antibody ELISA detects free (non-drug bound) antibodies to Adalimumab in serum and plasma.

IDK® Oncostatin M ELISA

Lab assay
The IDK Oncostatin M (OSM) ELISA is for the quantitative determination of oncostatin M in serum, plasma or stool samples. OSM and its receptor, OSMR, are involved in gut inflammation, and are upregulated in the mucosa of IBD patients.

Showing 37–43 of 43 results